Mats Hilmersson

Industry (incl. R&D)

Cavis Technologies AB - Uppsala, Sweden

Latest contributions

EuroPCR 2021 - Innovations in stable CAD

18 May 2021 – From EuroPCR 2021

In this session, consider the accuracy of OFR in assessing stenting result and residual disease, appraise a novel hybrid IVUS-OCT catheter system, and question whether NOCAD/INOCA patients could be diagnosed with a new physiological wire by obtaining pressure-derived CFR.

EuroPCR 2021 - Innovations in stable CAD